Xtant Medical Holdings Inc
$ 0.44
0.34%
07 Aug - close price
- Market Cap 62,218,000 USD
- Current Price $ 0.44
- High / Low $ 0.45 / 0.43
- Stock P/E 44.42
- Book Value 0.35
- EPS 0.01
- Next Earning Report 2026-08-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.04 %
- 52 Week High 0.95
- 52 Week Low 0.39
About
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.
Analyst Target Price
$1.35
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-13 | 2026-03-31 | 2025-11-10 | 2025-08-12 | 2025-05-12 | 2025-03-06 | 2024-11-12 | 2024-08-08 | 2024-04-01 | 2024-02-13 | 2023-11-09 | 2023-08-01 |
| Reported EPS | -0.02 | -0.0141 | 0.01 | 0.03 | 0.01 | -0.0134 | -0.04 | -0.02 | -0.02 | -0.03 | 0.07 | -0.02 |
| Estimated EPS | -0.02 | -0.005 | -0.01 | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
| Surprise | 0 | -0.0091 | 0.02 | 0.05 | 0.02 | 0.0066 | -0.02 | 0 | 0 | -0.01 | 0.08 | 0 |
| Surprise Percentage | 0% | -182% | 200% | 250% | 200% | 33% | -100% | 0% | 0% | -50% | 800% | 0% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-11 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: XTNT
2026-08-08 05:39:58
Xtant Medical Holdings, Inc. has released the results of its 2026 Annual Meeting of Stockholders, confirming the election of all six director nominees and the ratification of Grant Thornton LLP as its independent auditor. The report highlights strong shareholder participation at 74.47% and emphasizes governance stability. This 8-K filing is a standard update, providing continuity and reassurance regarding the company's leadership and financial oversight, with no indications of transactional or strategic shifts.
2026-08-07 01:40:08
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for the second quarter ended June 30, 2026, before the start of trading on Tuesday, August 11, 2026. President and CEO Sean Browne and CFO Scott Neils will host a conference call on the same day at 8:30 AM ET to discuss the results. A replay of the call will be available on the company's website under "Investor info."
2026-08-06 22:39:58
Xtant Medical Holdings, Inc. announced that it will release its second quarter 2026 financial results on Tuesday, August 11, 2026, before market open. The company's President and CEO, Sean Browne, and CFO, Scott Neils, will host a conference call at 8:30 AM ET on the same day to discuss the results. A webcast link and dial-in details were provided for interested participants.
2026-08-06 12:10:10
Xtant Medical (NYSE American: XTNT) announced it will release its second-quarter 2026 financial results on Tuesday, August 11, 2026, before the market opens. Following the release, the company's President and CEO, Sean Browne, and CFO, Scott Neils, will host a conference call and live webcast at 8:30 AM ET to discuss the results. Details for dialing into the call and accessing the webcast have been provided, with a replay available on the company's website.
2026-08-04 19:42:03
Xtant Medical (NYSE American: XTNT) announced that its CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026, at 2:00 pm ET. A live webcast and 90-day replay will be available on the company's investor website. Investors interested in scheduling one-on-one meetings with management during the August 11-13 conference should contact their Canaccord Genuity representative.
2026-08-04 19:42:03
Xtant Medical Holdings, Inc. announced its participation in the Canaccord Genuity 46th Annual Growth Conference, taking place from August 11-13, 2026, in Boston. CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger will represent the company. Their presentation is scheduled for August 11th at 2:00 pm ET, with a live webcast and a 90-day replay available on Xtant's Investors website.
